Navigation Links
Farnsworth 100 Hue

ProductsFarnsworth 100 Hue
Company Richmond Products, Inc.
Item Farnsworth 100 Hue
Features Inquire
Description The Richmond Products version of the Farnsworth 100 Hue Test comes boxed in clear acrylic containers which make scoring easy and reduces the potential for test disruption by holding the patients disc sequence intact. The Farnsworth 100 Hue test from Richmond Products includes 93 color discs, four clear Acrylic boxes, a tray, a durable laminated score template for copying, a supply of finger tip covers for the test subjects fingers (to maintain cleanliness and accuracy of the color discs), comprehensive instructions and a CD disk with a scoring template for use with MS-Excel. The scoring template calculates a numerical score and provides a graphical display or print of the patients score.
Info Richmond Products, Inc.Call Richmond Products, Inc. to buy products (US and Canada only; other locations use number below) USACanada1-866-435-4770

Customer Service: 505-275-2406
Web site: http://www.richmondproducts.com

Related medicine products :

1. Magnetic Farnsworth D15 Kit
2. Farnsworths D15 Test
3. Farnsworth D-15 Test
4. Farnsworth Panel D15 test evaluation
5. Farnsworth 100 Hue Test
6. Magnetic Farnsworth D15 kit
7. Farnsworth-Munsell 100 Hue Test
8. Farnsworth D15
Breaking Medicine Technology:Hand Surgeons Take Ethics into Their Own Hands 2Hand Surgeons Take Ethics into Their Own Hands 3Hand Surgeons Take Ethics into Their Own Hands 4Berger & Montague, P.C., Files Class Action Against Hemispherx Biopharma, Inc. Extending the End of the Class Period to December 1, 2009, When the Company Announced That the FDA Found No Evidence of Efficacy of Its Drug 2Berger & Montague, P.C., Files Class Action Against Hemispherx Biopharma, Inc. Extending the End of the Class Period to December 1, 2009, When the Company Announced That the FDA Found No Evidence of Efficacy of Its Drug 3FDA Grants Cequent IND - Clears Way for First-Ever Clinical Trial of Orally Delivered RNAi Therapeutic: CEQ508, a tkRNAi Drug Candidate in Oncology 2FDA Grants Cequent IND - Clears Way for First-Ever Clinical Trial of Orally Delivered RNAi Therapeutic: CEQ508, a tkRNAi Drug Candidate in Oncology 3FDA Grants Cequent IND - Clears Way for First-Ever Clinical Trial of Orally Delivered RNAi Therapeutic: CEQ508, a tkRNAi Drug Candidate in Oncology 4One in Seven Seniors Faces Social Security Check Cuts in 2010 48435 1One in Seven Seniors Faces Social Security Check Cuts in 2010 48435 2Kuvan Receives Priority Review Status From Health Canada 12563 1Kuvan Receives Priority Review Status From Health Canada 12563 2Kuvan Receives Priority Review Status From Health Canada 12563 3Kuvan Receives Priority Review Status From Health Canada 12563 4PDL BioPharma Announces Record Date for October 1 Dividend Payment 48432 1